These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16162110)

  • 1. Altered metabolism of tacrolimus in hepatic veno-occlusive disease.
    Mori T; Shimizu T; Yamazaki R; Nakazato T; Ikeda Y; Okamoto S
    Transpl Int; 2005 Oct; 18(10):1215-7. PubMed ID: 16162110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.
    Pihusch M; Wegner H; Goehring P; Salat C; Pihusch V; Andreesen R; Kolb HJ; Holler E; Pihusch R
    Bone Marrow Transplant; 2005 Oct; 36(7):631-7. PubMed ID: 16062176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
    Small TN; Young JW; Castro-Malaspina H; Prockop S; Wilton A; Heller G; Boulad F; Chiu M; Hsu K; Jakubowski A; Kernan NA; Perales MA; O'Reilly RJ; Papadopoulos EB
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):235-44. PubMed ID: 17241929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Veno-occlusive disease in a male patient with Marfan syndrome and common acute lymphoblastic leukemia during induction therapy.
    Kraemer DM; Waschke J; Kunzmann V; Wilhelm M
    Ann Hematol; 2003 Jul; 82(7):444-7. PubMed ID: 12761649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial.
    Platzbecker U; von Bonin M; Goekkurt E; Radke J; Binder M; Kiani A; Stoehlmacher J; Schetelig J; Thiede C; Ehninger G; Bornhäuser M
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):101-8. PubMed ID: 19135948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic veno-occlusive disease due to tacrolimus in a single-lung transplant patient.
    Shah S; Budev M; Blazey H; Fairbanks K; Mehta A
    Eur Respir J; 2006 May; 27(5):1066-8. PubMed ID: 16707401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone.
    Al Beihany A; Al Omar H; Sahovic E; Chaudhri N; Al Mohareb F; Al Sharif F; Al Zahrani H; Al Shanqeeti A; Seth P; Zaidi S; Morshed M; Al Anazi K; Mohamed G; Gyger M; Aljurf M
    Bone Marrow Transplant; 2008 Feb; 41(3):287-91. PubMed ID: 17982501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution.
    Kami M; Mori S; Tanikawa S; Akiyama H; Onozawa Y; Tanaka T; Okamoto R; Maeda Y; Sasaki T; Kaku H; Matsuura Y; Hiruma K; Sakamaki H
    Bone Marrow Transplant; 1997 Sep; 20(5):397-402. PubMed ID: 9339756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
    Cesaro S; Pillon M; Talenti E; Toffolutti T; Calore E; Tridello G; Strugo L; Destro R; Gazzola MV; Varotto S; Errigo G; Carli M; Zanesco L; Messina C
    Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
    Park SH; Lee MH; Lee H; Kim HS; Kim K; Kim WS; Jung CW; Im YH; Yoon SS; Kang WK; Park K; Park CH; Kim SW
    Bone Marrow Transplant; 2002 Jan; 29(2):137-43. PubMed ID: 11850708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantation.
    Shin SH; Yahng SA; Yoon JH; Lee SE; Cho BS; Kim YJ
    Blood Res; 2013 Mar; 48(1):55-7. PubMed ID: 23589797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide.
    Shah MS; Jeevangi NK; Joshi A; Khattry N
    J Cancer Res Ther; 2009; 5(4):312-4. PubMed ID: 20160371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening veno-occlusive disease after living-related liver transplantation.
    Nakazawa Y; Chisuwa H; Mita A; Ikegami T; Hashikura Y; Terada M; Nakayama J; Kawasaki S
    Transplantation; 2003 Mar; 75(5):727-30. PubMed ID: 12640317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection.
    Sebagh M; Debette M; Samuel D; Emile JF; Falissard B; Cailliez V; Shouval D; Bismuth H; Reynès M
    Hepatology; 1999 Nov; 30(5):1144-50. PubMed ID: 10534334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
    Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
    Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic veno-occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Mori T; Aisa Y; Shimizu T; Yamazaki R; Mihara A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Am J Hematol; 2007 Sep; 82(9):838-9. PubMed ID: 17506069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
    Mori T; Aisa Y; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Yamane A; Ikeda Y; Okamoto S
    Transplant Proc; 2007 Jun; 39(5):1615-9. PubMed ID: 17580201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.
    Najima Y; Ohashi K; Miyazawa M; Nakano M; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
    Am J Hematol; 2009 May; 84(5):298-301. PubMed ID: 19338041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.